Glucose Metabolism Disorders Clinical Trials

7 recruiting

Frequently Asked Questions

Common questions about Glucose Metabolism Disorders clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 1Phase 2

A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

Metabolic DiseaseDiabetes Mellitus, Type 1Type 1 Diabetes+14 more
Otsuka Pharmaceutical Factory, Inc.13 enrolled1 locationNCT06575426
Recruiting
Not Applicable

Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult Care

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+4 more
Anne-Sophie Brazeau200 enrolled4 locationsNCT05910840
Recruiting
Not Applicable

Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS)

Metabolic DiseaseGestational DiabetesGlucose Metabolism Disorders
KK Women's and Children's Hospital300 enrolled1 locationNCT05081037
Recruiting
Phase 2

Regulation of Endogenous Glucose Production by Central KATP Channels

Glucose, High BloodType 2 Diabetes MellitusGlucose Metabolism Disorders
Meredith Hawkins100 enrolled1 locationNCT03540758
Recruiting

Glucose Variability and Cognition in Prediabetes

DepressionCognitive DeclinePrediabetes+3 more
University of Maryland, Baltimore30 enrolled1 locationNCT04201600
Recruiting
Not Applicable

Cognitive-Behavioral Therapy and Exercise Training in Adolescents At-Risk for Type 2 Diabetes

Insulin ResistanceHyperinsulinismDepression+5 more
Colorado State University300 enrolled2 locationsNCT05543083
Recruiting
Not Applicable

Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs

Diabetes MellitusCardiovascular DiseasesDiabetes Mellitus, Type 2+16 more
C5 Biomedical177 enrolled1 locationNCT06674980
Recruiting
Not Applicable

Evaluating a Digital Intervention for Alleviating Diabetes-specific Emotional Distress in Adults Living With T2DM

Metabolic DiseaseDiabetes Mellitus, Type 2Endocrine System Diseases+1 more
Gaia AG250 enrolled1 locationNCT06529965
Recruiting
Not Applicable

In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 Diabetes

Diabetes MellitusBody WeightMetabolic Disease+9 more
Cornell University60 enrolled1 locationNCT06557317
Recruiting
Phase 1Phase 2

An Open-Label, FIH Study Evaluating the Safety, Tolerability, and Efficacy of VCTX211 Combination Product in Subjects With T1D

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+4 more
CRISPR Therapeutics AG40 enrolled2 locationsNCT05565248
Recruiting
Not Applicable

RT-CGM in Young Adults at Risk of DKA

Diabetes MellitusMetabolic DiseaseDiabetes Mellitus, Type 1+3 more
Imperial College London20 enrolled1 locationNCT04039763